Catalyst Wire Dossier Catalyst Wire Dossier

Glidipion

pioglitazone hydrochloride · Actavis Group PTC ehf
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Glidipion, covering 2022-10-17 to 2022-10-17. Get the full timeline:

Most recent: EMA Withdrawn: Glidipion (previously Pioglitazone Actavis Group) (pioglitazone hydrochloride) — Actavis Group PTC ehf

See pricing